Phase II trial of luspatercept with or without hydroxyurea for the treatment of patients with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis or unclassifiable with ring sideroblasts.

被引：0
|
作者：
Mangaonkar, Abhishek Avinash
Yi, Cecilia Ysabel Arana
Murthy, Hemant S.
Badar, Talha
Foran, James M.
Geyer, Susan Michelle
McCullough, Kristen Beth
Lola, Erinayo S. Baba
Hanson, Jean
Al-Kali, Aref
Alkhateeb, Hassan B.
Shah, Mithun Vinod
Begna, Kebede
Elliott, Michelle A.
Gangat, Naseema
Litzow, Mark Robert
Wolanskyj-Spinner, Alexandra P.
Hogan, William J.
Tefferi, Ayalew
Patnaik, Mrinal
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Scottsdale, AZ USA
[3] Mayo Clin, Jacksonville, FL USA
[4] Mayo Clin, Div Hematol, Jacksonville, FL USA
[5] Ohio State Univ, Columbus, OH USA
[6] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS7080
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
    Komrokji, Rami S.
    Platzbecker, Uwe
    Fenaux, Pierre
    Zeidan, Amer M.
    Garcia-Manero, Guillermo
    Mufti, Ghulam J.
    Santini, Valeria
    Diez-Campelo, Maria
    Finelli, Carlo
    Jurcic, Joseph G.
    Greenberg, Peter L.
    Sekeres, Mikkael A.
    DeZern, Amy E.
    Savona, Michael R.
    Shetty, Jeevan K.
    Ito, Rodrigo
    Zhang, George
    Ha, Xianwei
    Backstrom, Jay T.
    Verma, Amit
    LEUKEMIA, 2022, 36 (05) : 1432 - 1435
  • [2] Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
    Rami S. Komrokji
    Uwe Platzbecker
    Pierre Fenaux
    Amer M. Zeidan
    Guillermo Garcia-Manero
    Ghulam J. Mufti
    Valeria Santini
    María Díez-Campelo
    Carlo Finelli
    Joseph G. Jurcic
    Peter L. Greenberg
    Mikkael A. Sekeres
    Amy E. DeZern
    Michael R. Savona
    Jeevan K. Shetty
    Rodrigo Ito
    George Zhang
    Xianwei Ha
    Jay T. Backstrom
    Amit Verma
    Leukemia, 2022, 36 : 1432 - 1435
  • [3] Treatment outcomes for patients with myelodysplastic syndrome/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis
    Komrokji, Rami
    Melody, Megan
    Al Ali, Najla
    Chan, Onyee
    Klimek, Virginia
    Ball, Brian J.
    Sekeres, Mikkael A.
    Lucas, George
    Maciejewski, Jaroslaw P.
    Sallman, David A.
    Padron, Eric
    Kuykendall, Andrew
    Lasho, Terra
    Al-Kali, Aref
    Naqvi, Kiran
    Steensma, David P.
    Garcia-Manero, Guillermo
    Patnaik, Mrinal M.
    LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 199 - 204
  • [4] Efficacy of Lenalidomide in Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts
    Girodon, Francois
    Plocque, Alexia
    Voillat, Laurent
    Broseus, Julien
    Guerci, Agnes
    BLOOD, 2017, 130
  • [5] Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
    Edahiro, Yoko
    Ochiai, Tomonori
    Hashimoto, Yoshinori
    Morishita, Soji
    Shirane, Shuichi
    Inano, Tadaaki
    Furuya, Chiho
    Koike, Michiaki
    Noguchi, Masaaki
    Usuki, Kensuke
    Shiratsuchi, Motoaki
    Nakajima, Kei
    Ohtsuka, Eiichi
    Tanaka, Hiroaki
    Kawata, Eri
    Nakamae, Mika
    Ueda, Yasunori
    Aota, Yasuo
    Sugita, Yasumasa
    Ohara, Shin
    Yamasaki, Satoshi
    Asagoe, Kohsuke
    Yoshida, Shuro
    Yamanouchi, Jun
    Suzuki, Sayaka
    Kondo, Toshinori
    Kanisawa, Yuji
    Toyama, Kohtaro
    Omura, Hiromi
    Mizuchi, Daisuke
    Sakamaki, Sumio
    Ando, Miki
    Komatsu, Norio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 47 - 53
  • [6] Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist
    Li, Peng
    Shahmarvand, Nahid
    Lynch, David
    Gotlib, Jason R.
    Merker, Jason D.
    Zehnder, James L.
    George, Tracy, I
    Ohgami, Robert S.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (03) : 345 - 352
  • [7] Clinical characteristics of Japanese patients with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis
    Yoko Edahiro
    Tomonori Ochiai
    Yoshinori Hashimoto
    Soji Morishita
    Shuichi Shirane
    Tadaaki Inano
    Chiho Furuya
    Michiaki Koike
    Masaaki Noguchi
    Kensuke Usuki
    Motoaki Shiratsuchi
    Kei Nakajima
    Eiichi Ohtsuka
    Hiroaki Tanaka
    Eri Kawata
    Mika Nakamae
    Yasunori Ueda
    Yasuo Aota
    Yasumasa Sugita
    Shin Ohara
    Satoshi Yamasaki
    Kohsuke Asagoe
    Shuro Yoshida
    Jun Yamanouchi
    Sayaka Suzuki
    Toshinori Kondo
    Yuji Kanisawa
    Kohtaro Toyama
    Hiromi Omura
    Daisuke Mizuchi
    Sumio Sakamaki
    Miki Ando
    Norio Komatsu
    International Journal of Hematology, 2023, 118 : 47 - 53
  • [8] Revisiting Diagnostic Criteria for Myelodysplastic and Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis: Borderline Cases without Anemia Exist
    Li, Peng
    Ohgami, Robert S.
    LABORATORY INVESTIGATION, 2018, 98 : 532 - 532
  • [9] Revisiting Diagnostic Criteria for Myelodysplastic and Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis: Borderline Cases without Anemia Exist
    Li, Peng
    Ohgami, Robert S.
    MODERN PATHOLOGY, 2018, 31 : 532 - 532
  • [10] Extramedullary myelodysplastic/myeloproliferative neoplasm (MDS/MPN) with ring sideroblasts and thrombocytosis
    Kerneves, Pauline
    Cornet, Edouard
    Paubelle, Etienne
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (05) : 890 - 891
12345